Duterte Open to Use of Controversial Vaccine Amid Spike in Dengue Cases
DUTERTE – President Rodrigo Roa Duterte said that he was open to the return of dengvaxia amid the national dengue alert.
Dengaxia vaccine was launched during the term of former President Benigno Noynoy Aquino III. However, it was removed to the market after it failed to comply with the requirements of the Food and Drugs Administration (FDA).
The makers of the vaccine, Sanofi Pasteur, admitted that the vaccine may trigger severe symptoms if injected to victims who have never contracted the virus.
On June 2019, the Department of Health (DOH) declared a ‘nationwide dengue alert’ after the increasing number of victims.
In a previous article, Noynoy Aquino supported the return of the controversial vaccine amid dengue outbreak.
“Kung wala naman talagang idinudulot na masama itong gamot na ito at nakakatulong, bakit nga hindi gamitin?.. maibsan man lang ‘yung nadadama ng marami nating kababayan na nasa daang libo nang tinamaan nitong dengue,” Aquino said.
Based on a report from ABS-CBN News, the dengue cases in the country is rapidly increasing. Several regions are currently in a state of calamity because of the mosquito-borne disease.
Philippine President Rodrigo Roa Duterte said he was open to making the vaccine available again in the country.
“I am open to the use of Dengvaxia again. Maraming patay na… It’s an epidemic,” Duterte said.
The statement of the president elicited mixed reactions from the netizens. Here are some of their comments on the post:
@william nisola: “Tama lang kung ibalik ulit kung makakabuti sa mga pinoy walang pulitika pag dating sa kalusugan ng mga mamayan Filipino”
@asianolee de guzman: “naku mr president pag pina open mo yan unahin mo muna pa turukan si mr duque para malaman natin at yung ibang doctor na gusto i-open yan”
@Artistic Minds: “Eh di nabuking kayo ngayon. Ginawan lang ninyo ng issue laban sa dating administrasyon para magmukhang magaling kayo.”
What can you say about this article? Leave your comment and reactions below.